1. Home
  2. ABEO vs RCAT Comparison

ABEO vs RCAT Comparison

Compare ABEO & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.82

Market Cap

307.5M

Sector

Health Care

ML Signal

HOLD

Logo Red Cat Holdings Inc.

RCAT

Red Cat Holdings Inc.

HOLD

Current Price

$10.67

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEO
RCAT
Founded
1974
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
307.5M
1.9B
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
ABEO
RCAT
Price
$5.82
$10.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$20.00
$20.00
AVG Volume (30 Days)
948.8K
18.2M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
165.16
N/A
EPS
N/A
N/A
Revenue
$2,998,000.00
$17,836,382.00
Revenue This Year
$1,024.31
$271.60
Revenue Next Year
$145.42
$41.21
P/E Ratio
N/A
N/A
Revenue Growth
258.18
79.95
52 Week Low
$4.00
$5.77
52 Week High
$7.54
$18.78

Technical Indicators

Market Signals
Indicator
ABEO
RCAT
Relative Strength Index (RSI) 57.14 44.08
Support Level $5.24 $10.52
Resistance Level $6.01 $13.69
Average True Range (ATR) 0.23 1.24
MACD 0.02 -0.21
Stochastic Oscillator 76.60 3.47

Price Performance

Historical Comparison
ABEO
RCAT

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

About RCAT Red Cat Holdings Inc.

Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.

Share on Social Networks: